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Cervical artery dissection (CeAD) is a rare condition. One of the causes is the vascular type of Ehlers
eDanlos syndrome (vEDS). A novel missense mutation in COL3A1 was found in a young patient with
CeAD as the single manifestation of vEDS. This is a heterozygous c.953G > A mutation in exon 14, dis-
rupting the normal Gly-X-Y repeats of type III procollagen, by converting glycine to aspartic acid.
© 2015 Elsevier Masson SAS. All rights reserved.1. Introduction
Cervical artery dissection (CeAD) includes carotid and vertebral
artery dissection, and represents an important cause of ischemic
stroke in young adults (Debette, 2014). CeAD is a relatively rare and
complex disorder with genetic (multifactorial, monogenic disorder)
and environmental (cervical trauma, recent infection, hyperten-
sion, migraine) predisposing risk factors. The annual incidence is
estimated around 2.6 to 3 cases per 100,000 people. Morphologi-
cally, CeAD is manifested as a mural hematoma, double lumen,
aneurysmal dilatation, tapering stenosis, intimal ﬂap, or occlusion
of the affected artery. Despite a rare cause of CeAD, monogenic
connective tissue diseases (CTD) must always be taken into
consideration due to their severe complications. The most frequent
detected among them are the vascular type of EhlerseDanlos
syndrome (vEDS), ﬁbromuscular dysplasia, Marfan syndrome, and
osteogenesis imperfecta.lar Surgery, Surgical Research
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rygiannis).
erved.
annis, G., et al., Cervical arte
pe EhlerseDanlos syndromevEDS is a rare autosomal dominant disease with an incidence
of 0.2e1 case per 100,000 people and median survival of 48
years. The diagnosis is conﬁrmed by the detection of abnormal
type III procollagen or of a mutation in the COL3A1 gene, and is
based on the presence of at least two out of four major diagnostic
criteria (Beighton et al., 1998) (thin translucent skin with visible
veins, extensive-easy bruising, characteristic facial appearance,
arterial, intestinal or uterine fragility or rupture). Of note, CeAD
has been odserved in 2% of patients with genetically described
vEDS (North et al., 1995, Pepin et al., 2000), and vEDS was found
in less than 2% among large CeAD series (Debette and Markus,
2009). Although vEDS appears to be genetically homogeneous,
there is remarkable allelic heterogeneity, which results in varied
natural history with gender and type of mutation of a COL3A1
(Pepin et al., 2014). Here we describe a case of a young woman
with CeAd as the single manifestation of genetically veriﬁed
vEDS.
2. Case presentation and diagnosis
A 21-year-old woman admitted to the emergency department
for severe neck pain of the left side radiating to head and shoulders,ry dissections and type A aortic dissection in a family with a novel
, European Journal of Medical Genetics (2015), http://dx.doi.org/
Fig. 2. Pedigree; In grey member of the family heterozygous of the c.953G > A
(p.Gly318Asp) mutation in the exon 14 of COL3A1 gene, II:1; Type A aortic dissection,
III:1; Cervical artery dissections, II:2; heterozygous asymptomatic mutation carrier, I:1;
very old person to whom we did not perform genetic analysis.
G. Makrygiannis et al. / European Journal of Medical Genetics xxx (2015) 1e32vomiting, followed by paresis and paresthesia of the superior
members and chest during less than one hour. From her past
medical history she presented hypothyroidism, obesity, syndrome
of micro-polycystic ovaries and she was current smoker of 4e5
cigarettes/day.
Magnetic resonance imaging (MRI) and magnetic resonance
angiography (MRA) revealed dissection of the upper part of the
internal carotid artery before its entry at the base of cranium and
dissection of the vertical part of the left vertebral artery (Fig. 1).
Treatment consisted of low molecular weight heparin during hos-
pitalization substituted by warfarin for 6 months, and replaced by
acetylsalicylic acid. The patient did not present further neurologic
complications. Despite that no recent trauma was mentioned and
from the clinical examination the patient did not show any sign of
CTD, a CTD was suspected. A mutation analysis was performed by
sequencing of all coding exons, inclusive intron/exon boundaries of
the current thoracic aortic aneurysm and dissection panel (TAAD).
The current TAAD panel consists of the following genes: ACTA2,
COL3A1, EFEMP2/FBLN4, FBN1, FLNA, MYH11, MYLK, NOTCH1,
PRKG1eexon3, SKI, SLC2A10, SMAD3, TGFB2, TGFBR1 and TGFBR2.
Sequence analysis of the COL3A1 showed the presence of a het-
erozygous c.953G > A (p.Gly318Asp) mutation in exon 14 that has
not been reported before, disrupting the normal Gly-X-Y repeats of
type III procollagen. This mutation is not present in the COL3A1
mutation database (http://www.le.ac.uk/genetics/collagen/). How-
ever since this mutation affected a glycine residue of the collagen
helix, there is no doubt about its causality. Anecdotally, the same
period, the patient's 60 year-old maternal aunt (II:1) presented
with a type A aortic dissection and in the sequence analysis the
same mutation was identiﬁed. Further genetic testing that was
conducted to the family revealed the samemutation in the patient's
mother (II:2), whereas the remaining members of the family were
found negative (II:4, III:2, III:3, III:4) (Fig. 2). An angiographic
investigation performed at the level of cervical arteries and thor-
acoabdominal aorta did not reveal any pathology, nor typical signs
of vEDS were found in the 59 year-old mother. I:2 suffered from
spontaneous intestinal rupture which was treated by colectomy
and after many years she died from sudden death. A written
informed consent and authorization to use the blood samples and
images for research were obtained from the patients or their
relatives.Fig. 1. a; MRI of the head, axial T2-weighted Turbo Spin Echo sequence shows the presence
view, shows the dissection of the vertical part of the left vertebral artery (arrows).
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Here we present a young patient with CeAD to whom a muta-
tion analysis was performed by sequencing of all codings exons,
inclusive intron/exon boundaries using a next generation
sequencing gene panel for the current TAAD panel. The sequence
analysis showed a heterozygous G to A transition at cDNA position
953 in exon 14 of the COL3A1 gene, which converts glycine to
aspartic acid at amino acid position 318 disrupting the normal Gly-
X-Y repeats of type III procollagen. This is a novel ﬁnding that has
never been reported before in vEDS. In general, approximately 50%
of affected individuals inherit the COL3A1 mutation from an
affected parent, whilst the rest 50% of affected individuals carry a de
novo disease-causing mutation.
CeAD is not common in vEDS, counting less than 2% of the cases
according to large published series (Debette, 2014). Among all
vascular complications of vEDS about one quarter involves head
and neck vessels, including carotid-cavernous ﬁstula, CeAD, intra-
cranial aneurysms and arterial rupture (Pepin et al., 2000). The
presentation of vEDS is extremely variable, and in this case the
patient presented only one of the four major diagnostic criteria
(Beighton et al., 1998). Although recently some phenoty-
peegenotype correlations have been suggested (Frank et al., 2015,of the dissection of the left internal carotid artery (arrows), b; MRA of the neck, coronal
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members within the same family (Kuivaniemi et al., 1997).
Reducing penetrance of vEDS has been observed in families with
haploinsufﬁciencymutations, but it is rather uncommon in families
with missense mutations (http://www.ncbi.nlm.nih.gov/books/
NBK1494/). These atypical forms of vEDS should increase aware-
ness of this rare autosomal dominant disease and indicates that the
same mutation in different relatives in the same family can be
related with variable phenotypic expression. Currently, treatment
is symptomatic and celiprolol has been proposed for the prevention
of vascular complications of the vEDS (Ong et al., 2010). The study of
different animal models could be useful to elucidate the patho-
genesis of the disease and to identify therapeutic targets. This
paradigm of a young patient showing atypical presentation should
sensibilize physicians for early suspicion and detection of this
syndrome. Caution should be exercised as vEDS patients are at
increased risk of vessel rupture after endovascular interventions, at
high bleeding risk under treatment with anticoagulants, and mo-
lecular genetic testing and clinical evaluation should be offered to
at-risk patients.
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